Protecting Children: Influenza Updates for Clinicians

Date:Thursday, February 26, 2015

Presenter(s)

Overview

A recent analysis by the Centers for Disease Control and Prevention (CDC) has found influenza A (H3N2) viruses are the predominant strain this year, and a little more than half of samples analyzed were found to be antigenically different (drifted) from the H3N2 vaccine strain. During this COCA Webinar, clinicians will learn about the current state of flu activity related to children, the importance of continued vaccination despite the mismatch and low vaccine effectiveness, and strategies for using antiviral therapy early to prevent and treat influenza.

Objectives

At the conclusion of the session, the participant will be able to accomplish the following:

• Describe strategies to assist clinicians in caring for children for the remainder of the 2014-2015 influenza season.
• Identify approaches and emphasize the value for using antiviral therapy in children.
• Discuss ways to encourage continued vaccination despite the drifted influenza A (H3N2) viruses.

Call Materials

• Slides:View Now
• Audio: Listen Now
• Webcast: Watch Now
• Transcript:Read Now

Additional Resources

• CDC Influenza Information for Health Professionals
• CDC Influenza Activity and Surveillance

Call Format

• Audio conference call on 2/26/15: 2:00 - 3:00 PM
• Web-on-demand training after 3:00 PM on 2/26/15
• Materials: PowerPoint slide set

Accreditation Statements

Accreditation Statements

CME:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME^®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE:The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity provides 1.0 contact hour.

IACET CEU:The CDC has been approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, Suite 500, McLean, VA 22102. The CDC is authorized by IACET to offer 1.0 ANSI/IACET CEU's for this program.

CECH:Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 0 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number GA0082.

CPE:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 1.0 Contact Hour in pharmacy education. The Universal Activity Number is 0387-0000-15-089-L04-P and enduring 0387-0000-15-089-H04-P course category.

This program is knowledge based.

AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 1.2 hours of continuing education in the jurisdictions which recognize AAVSB RACE approval. Please contact the AAVSB RACE Program at race@aavsb.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.

DISCLOSURE:In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.

The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC does not accept commercial support.